Ouachita Baptist University

Scholarly Commons @ Ouachita
Articles

Faculty Publications

7-1-2018

Hypoxia-derived exosomes induce putative altered pathways in
biosynthesis and ion regulatory channels in glioblastoma cells
Rajshekhar A. Kore
University of Arkansas for Medical Sciences

Jacob L. Edmondson
Ouachita Baptist University

Samir V. Jenkins
University of Arkansas for Medical Sciences

Azemat Jamshidi-Parsian
University of Arkansas for Medical Sciences

Ruud P.M. Dings
University of Arkansas for Medical Sciences

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.obu.edu/articles
Part of the Cancer Biology Commons

Recommended Citation
Kore, Rajshekhar A.; Edmondson, Jacob L.; Jenkins, Samir V.; Jamshidi-Parsian, Azemat; Dings, Ruud P.M.;
Reyna, Nathan S.; and Griffin, Robert J., "Hypoxia-derived exosomes induce putative altered pathways in
biosynthesis and ion regulatory channels in glioblastoma cells" (2018). Articles. 334.
https://scholarlycommons.obu.edu/articles/334

This Article is brought to you for free and open access by the Faculty Publications at Scholarly Commons @
Ouachita. It has been accepted for inclusion in Articles by an authorized administrator of Scholarly Commons @
Ouachita. For more information, please contact mortensona@obu.edu.

Authors
Rajshekhar A. Kore, Jacob L. Edmondson, Samir V. Jenkins, Azemat Jamshidi-Parsian, Ruud P.M. Dings,
Nathan S. Reyna, and Robert J. Griffin

This article is available at Scholarly Commons @ Ouachita: https://scholarlycommons.obu.edu/articles/334

Biochemistry and Biophysics Reports 14 (2018) 104–113

Contents lists available at ScienceDirect

Biochemistry and Biophysics Reports
journal homepage: www.elsevier.com/locate/bbrep

Hypoxia-derived exosomes induce putative altered pathways in biosynthesis
and ion regulatory channels in glioblastoma cells

T

Rajshekhar A. Korea, Jacob L. Edmondsonb, Samir V. Jenkinsa, Azemat Jamshidi-Parsiana,
⁎
Ruud P.M. Dingsa, Nathan S. Reynab, Robert J. Griﬃna,
a
b

Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Biology Department, Ouachita Baptist University, Arkadelphia, AR 71998, USA

A R T I C LE I N FO

A B S T R A C T

Keywords:
Exosomes
Hypoxia
Glioblastoma
Transcriptome
Proteomics
Angiogenesis

Hypoxia, a hallmark characteristic of glioblastoma (GBM) induces changes in the transcriptome and the proteome of tumor cells. We discovered that hypoxic stress produces signiﬁcant qualitative and quantitative
changes in the protein content of secreted exosomes from GBM cells. Among the proteins found to be selectively
elevated in hypoxic exosomes were protein-lysine 6-oxidase (LOX), thrombospondin-1 (TSP1), vascular derived
endothelial factor (VEGF) and a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1),
well studied contributors to tumor progression, metastasis and angiogenesis. Our ﬁndings demonstrate that
hypoxic exosomes induce diﬀerential gene expression in recipient glioma cells. Glioma cells stimulated with
hypoxic exosomes showed a marked upregulation of small nucleolar RNA, C/D box 116–21 (SNORD116-21)
transcript among others while signiﬁcantly downregulated the potassium voltage-gated channel subfamily J
member 3 (KCNJ3) message. This diﬀerential expression of certain genes is governed by the protein cargo being
transferred via exosomes. Additionally, compared to normoxic exosomes, hypoxic exosomes increased various
angiogenic related parameters vis-à-vis, overall tube length, branching intervals and length of isolated branches
studied in tube formation assay with endothelial progenitor cells (EPCs). Thus, the intercellular communication
facilitated via exosomes secreted from hypoxic GBM cells induce marked changes in the expression of genes in
neighboring normoxic tumor cells and possibly in surrounding stromal cells, many of which are involved in
cancer progression and treatment resistance mechanisms.

1. Introduction
With a very poor survival of 14–16 months in newly diagnosed
patients, GBM accounts for more than 50% of malignant gliomas [1–3].
Surgical resection of tumors with accompanying or concurrent radiation or chemotherapy, either alone or in combination, has not been an
entirely successful curative approach for treating GBM. The tumors
almost always recur either a short distance from the resected area or in
some other part of the brain [4–7]. In many cancers, including GBM,
exosomes deliver potentially oncogenic cargo leading to modulation of
tissue microenvironment and progression of the disease [8–10]. Endosomal in origin, exosomes constitute a set of vesicles, 30–100 nm in
size, secreted by various cell types [11–14]. They are involved in
mediating intercellular communication by shuttling or transferring
protein and genetic information [15–17]. We have previously reported
that modulating a cell’s microenvironment with pro-inﬂammatory cytokines induces changes in the protein cargo of secreted exosomes,

⁎

which in turn exert their eﬀect on nearby or far away recipient cells
[18]. In addition to inﬂammation, necrosis is another distinguishing
feature of GBM tumors [19,20]. Necrosis results from rapid growth of
glioma cells resulting in competition of dividing cells for metabolic
demands, from vascular thrombosis or from hypoxia in the central region of the tumors [21]. Along with necrosis, a hypoxic, yet viable,
microenvironment is a prominently observed feature during GBM progression and in response to various treatment regimens employed to
treat the disease [22–24]. These changes are linked to increased tumor
growth rate in many instances. Although hypoxia, inﬂammation, and
necrosis are hallmark characteristics of GBM tumors, and given their
resistance to apoptosis, there is no comprehensive evidence, as of yet,
on the eﬀects of hypoxia on exosomal cargo and its ramiﬁcation on
recipient cells.
Hypoxic stress induces changes in the transcriptome and the proteome of GBM cells [25–27]. A recent report shed light on some proteins being ferried via exosomes reﬂecting the hypoxic status of
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washed once in 70% ethanol followed by 4× washes with molecular
grade water. These grids were then loaded onto the sample holder of
the electron microscope (JEOL 100cx) and exposed to 100 kV electron
beam for capturing images.

secreting glioma cells [26]. Various angiogenic factors found in glioblastoma derived exosomes were shown to mediate stimulation of angiogenesis [10,26]. Cells incubated with exosomes, irrespective of the
origin of secreting cells, have also been shown to exhibit increased
invasiveness in a Matrigel™ based invasion assay [28].
The primary aim of our study was to determine the eﬀect of hypoxia
on the protein content of exosomes and its eﬀect on the global transcriptome of recipient cells that could go on to inﬂuence the characteristics of tumor progression. To understand the inﬂuence of hypoxia
on tumor derived exosomes and the resulting eﬀect of these exosomes
on the surrounding tumor or stromal cells, the proteomic proﬁle of
exosomes secreted by hypoxic glioma cells and the transcriptome of
cells treated with these exosomes was studied.

2.5. Confocal microscopy
U87MG cells grown to 90% conﬂuence in 4 chambered Lab-Tek
Borosilicate Coverglass system were cultured under normoxic or hypoxic conditions in presence of 200 μM pimonidazole. After 24 h of
culture under these conditions, cells were washed 3× with PBS and
ﬁxed with 4% paraformaldehyde for 20 min at room temp. The cells
were further washed 3× with PBS and permeabilized and simultaneously blocked with 0.1% Triton-x 100 in 3% BSA containing PBS.
Fixed cells were incubated with FITC conjugated primary antibody
against pimonidazole (1:500 dilution, Hydroxyprobe Inc, Burlington,
MA). Cells were washed and further incubated with antibodies against
HIF-1α and galectin-1. The secondary antibodies used were Goat antimouse AF647 and Goat anti-rabbit AF488 (at 1:1000 dilution). The cells
were counter stained with DAPI. Confocal images were acquired using
the LSM 880 confocal microscope using the x20 lens.

2. Methods and materials
2.1. Cell culture and reagents
Cell culture media – DMEM, phosphate buﬀered saline (PBS), penicillin/streptomycin were obtained from Corning(Thermo Fischer
Scientiﬁc, Waltham, MA), fetal bovine serum (FBS) from Atlanta
Biologicals Inc (Flowery Branch, GA). Pimonidazole was purchased
from Hydroxyprobe Inc (Burlington, MA). MTS assay reagent (celltiter
96 aqueous one solution cell proliferation assay) was purchased from
Promega Corporation (Madison, WI). The human glioma cell line,
U87MG was purchased from ATCC. EPC cells were a gift from Joyce E.
Bischoﬀ, Ph.D. at Boston Children’s Hospital.

2.6. In vitro angiogenesis (tube formation) assay
Overnight cell cultures of EPC cells grown to 80% conﬂuence were
used for experiments. Around 5000 cells were plated onto BD Matrigel
coated 96 well plates in presence of either normoxic or hypoxic glioma
exosomes. For control group, cells were cultured similarly, but without
exosomes. 24 hrs later, images of the formed tubes in the wells were
acquired. A total of 4 images (n = 4) for each sample were then processed through the FIJI imaging software using the plugin for angiogenesis analysis. The number of nodes, meshes, junctions and branching
intervals were noted and tabulated.

2.2. Cell culture and staining
U87MG cultures were maintained in complete DMEM media containing 10% FBS & 100 units/ml of penicillin/streptomycin at 37 °C in a
5% CO2 incubator. Overnight cell cultures grown to 80% conﬂuence
were used for experiments. For hypoxic conditions, cells cultured
overnight were washed 3x with PBS and fresh serum free DMEM media
was added and were then incubated for a further 18–24 h at 37 °C in an
anaerobic chamber (Forma Scientiﬁc) with an atmospheric mixture of
5% CO2, 10% H2, 85% N2 producing oxygen concentrations below
0.5%. For control group, cells were cultured similarly, but in a normal
37 °C 5% CO2 incubator. In both groups cells were cultured in presence
of 200 μM of the hypoxic marker, pimonidazole to allow assessment of
adducts formed in hypoxic- derived exosomes.
Endothelial progenitor cells (EPCs) were cultured in complete EGM2 BulletKit (Lonza, Morristown, NJ) medium containing 20% FBS and
1% penicillin streptomycin and L-glutamine.

2.7. Cell viability assay
Cell viability assay was performed according to the manufacturer’s
instructions. In brief, U87MG glioma cells were seeded into 96 well
plate at a density of 3000 cells per well and allowed to attach overnight
(16–18 h). After a fresh media change to exosome free complete
medium, the cells were then preincubated for 3 h with or without
exosomes. To this was added 0.5 mM hydrogen peroxide (H2O2) to induce oxidative stress and cells were incubated for a further 24 h in a
humidiﬁed, 5% CO2 atmosphere. To the cell culture medium in each
well was added 20 μl of the MTS reagent, incubated for a further 1–4 h
and the absorbance was read at 490 nm in a 96-well plate reader.

2.3. Exosome isolation
2.8. RNA sequencing
Conditioned media from U87MG cultures was collected and exosomes isolated by sequential centrifugation as previously described
[18,29]. In brief the pooled conditioned media from normoxic or hypoxic cells was subjected to sequential centrifugation at 300g for 10 min
and 10,000g for 30 min. The pellet formed was discarded and the supernatant was then subjected to ultracentrifugation at 100,000g for 2 h
to isolate the exosomes. The supernatant was discarded, the formed
exosome pellet was washed with PBS at 100,000g for 2 h and the
washing discarded. The exosome pellet was then resuspended in
30–50 μl PBS dependent on the analysis technique or experimental requirements downstream.

RNA was isolated from untreated and exosome treated U87MG cells
24 h post treatment using QIAGEN RNA-easy kit according to manufacturer’s speciﬁcations. RIN (RNA integrity number) 9 or higher for all
samples used for sequencing. RNA was prepared for sequencing by use
of the Illumina TruSeq mRNA Stranded Sample Preparation Kit
(Illumina Inc, San Diego, CA). Brieﬂy, messenger RNA (mRNA) was
puriﬁed from 500 ng of total RNA using poly A selection. The resultant
RNA was chemically fragmented and converted into single-stranded
cDNA in a reverse transcription reaction using random hexamer
priming. The second strand cDNA was generated, followed by end repair and the addition of a single ‘A’ base at each end of the molecule.
Adapters that are necessary for attachment to the sequencer ﬂow cell
surface were ligated to each end of the cDNA. The adapters also contain
unique sequences that serve as indices which allow samples to be
pooled for multiplexed sequencing and later downstream analysis. The
ligated cDNA served as the template for PCR ampliﬁcation to enrich the
ﬁnal cDNA library for sequencing.

2.4. Electron microscopy
Transmission electron images were obtained by adding 3 μl of
exosome suspension onto 200 mesh formvar coated grids and allowed
to dry at room temperature. The grids were washed with water, stained
with 1% uranyl acetate solution for 5 min. After staining, the grids were
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Fig. 1. Characterization of exosomes. TEM of isolated vesicles: Electron micrographs display sets of distinct vesicles isolated from U87MG cells cultured under (A) normoxic conditions with average diameters of 71 ± 14 nm
(C) while those derived from cells cultured under (B) hypoxic conditions had a slightly smaller average diameter of
61 ± 13 nm (C), (Scale bar: 100 nm). (D) Western blot
analysis of equivalent amounts cell lysates and exosomes
showed enrichment of CD63 in exosomes.

room temperature for 1 h. Blots were washed thoroughly 3x with TBS-t
and developed with a chemiluminescence developing reagent,
SuperSignal® West Femto Maximum sensitivity substrate (ThermoFisher
Scientiﬁc, Rockford, IL).

Sequencing cluster generation was accomplished on the Illumina
NextSeq. 500 to bind denatured cDNA library molecules to the sequencing ﬂow cell, followed by an isothermal reaction to amplify attached cDNAs, resulting in clonal clusters of approximately 1000 copies
each.
The sequence of ampliﬁed cDNA clusters ligated to the ﬂow cell was
determined by sequencing by synthesis using Illumina TruSeq SBS reagents on the Illumina NextSeq. 500 instrument.
Data was then analyzed on the web based Advaitha pathway analysis software. Diﬀerentially expressed gene list were obtained using a
threshold of 0.05 for statistical signiﬁcance (p-value) and a log fold
change of expression with absolute value of at least 0.6. These data
were analyzed in the context of pathways obtained from the Kyoto
Encyclopedia of Genes and Genomes (KEGG) database (Release
78.0 +/06-02, Jun 16) [30,31], gene ontologies from the Gene Ontology Consortium database [32] (Gene Ontology Consortium, 2001),
and diseases from the KEGG database [30,31].

2.10. Mass spectrometry (MS)
Exosomes were lysed in RIPA buﬀer and the proteins were reduced,
alkylated, and digested using ﬁlter-aided sample preparation [33].
Tryptic peptides were labeled using a tandem mass tag 6-plex isobaric
label reagent set (Thermo) following the manufacturer’s instructions.
Labeled peptides were separated into 36 fractions on a 100 × 1.0 mm
Acquity BEH C18 column (Waters) using an UltiMate 3000 UHPLC
system (Thermo) with a 40 min gradient from 99:1 to 60:40 buﬀer A:B
ratio under basic pH conditions, and then consolidated into 12 superfractions. Each super-fraction was then further separated by reverse
phase Jupiter Proteo resin (Phenomenex) on an in-line 200 ×
0.075 mm column using a nanoAcquity UPLC system (Waters). Peptides
were eluted using a 60 min gradient from 97:3 to 67:33 buﬀer A:B ratio.
Buﬀer A = 0.1% formic acid, 0.5% acetonitrile, Buﬀer B = 0.1% formic
acid, 99.9% acetonitrile, both buﬀers adjusted to pH 10 with ammonium hydroxide for oﬄine separation. Eluted peptides were ionized by
electrospray (2.15 kV) followed by mass spectrometric analysis on an
Orbitrap Fusion Tribrid mass spectrometer (Thermo) using multi-notch
MS3 parameters. MS data were acquired using the FTMS analyzer in
top-speed proﬁle mode at a resolution of 240,000 over a range of
375–1500 m/z. Following CID activation with normalized collision energy of 35.0, MS/MS data were acquired using the ion trap analyzer in
centroid mode over a range of 400–2000 m/z. Using synchronous precursor selection, up to 10 MS/MS precursors were selected for HCD
activation with normalized collision energy of 65.0, followed by acquisition of MS3 reporter ion data using the FTMS analyzer in proﬁle
mode at a resolution of 30,000 over a range of 100–500 m/z. Proteins
were identiﬁed and reporter ions quantiﬁed using MaxQuant (Max
Planck Institute) with a parent ion tolerance of 3 ppm, a fragment ion
tolerance of 0.5 Da, and a reporter ion tolerance of 0.01 Da. Scaﬀold Q
+S (Proteome Software) was used to verify MS/MS based peptide and
protein identiﬁcations (protein identiﬁcations were accepted if they

2.9. SDS-PAGE and western blotting
Around 7.5 μg or 10 μg of exosomal pellets and cell lysates, determined by BCA protein estimation, were boiled with 4× Laemmli’s
sample buﬀer containing 10% beta-mercaptoethanol and run on a
4–20% SDS-PAGE denaturing gel (Bio-Rad Laboratories, Hercules, CA).
The proteins were transferred to PVDF membranes using conventional
transfer apparatus. The membranes were blocked with 5% Bovine
serum albumin (BSA) dissolved in Tris-buﬀered saline (TBS) containing
0.01% tween-20 (TBS-t) for 1hr at room temp. Blots were probed sequentially with primary antibodies: rabbit anti-TSP-1 polyclonal antibody (1:1000), rabbit anti-LOX polyclonal antibody (1:1000), rabbit
anti-ADAMTS1 polyclonal antibody (1:1000), rabbit polyclonal antithrombospondin-1, (all from ThermoFisher Scientiﬁc, Rockford, IL),
rabbit polyclonal anti-CD63, (1:1000) (SBI Biosciences, Mountain View,
CA) or mouse monoclonal anti-β-actin (1:5000) (Cell Signaling
Technology, Beverly, MA)] diluted in blocking buﬀer for 1hr at room
temp. Blots were washed 3× with TBS-t and then incubated with horse
radish peroxide (HRP) conjugated anti-mouse or anti- rabbit antibody
(1:10,000) (Santa Cruz Biotech, Dallas, TX) diluted in blocking buﬀer at
106
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Fig. 2. MS and network analysis of hypoxic exosomal proteome. Ingenuity pathway analysis of 136 proteins that are elevated by 1.2 fold or greater in exosomes
secreted by hypoxic U87MG cells. Network mapping of secreted proteins detected in hypoxic exosomes by MS (n = 3) shows their cellular localization, their
interactive partners and the various biological functions that these proteins are potentially involved in. Nodes colored orange indicate upregulated pathways while
nodes colored blue indicate downregulated pathways.

For all results, statistical signiﬁcance was calculated using
GraphPad Prism’s one way ANOVA followed by Bonferroni’s multiple
comparison test and results were expressed as mean ± SEM. Value of
p < 0.05 was considered as statistically signiﬁcant.

under normoxic conditions. Furthermore, increased staining for HIF-1α,
upregulated under hypoxic conditions, also conﬁrmed the hypoxic
stress on U87MG cells. Exosomes were isolated from conditioned media
of both groups of cells by sequential centrifugation and characterized
by electron microscopy. Micropictograph analysis was used to conﬁrm
the morphology and determine the mean average diameters of the
exosomes, with normoxic exosomes being around 71 ± 14 nm (Fig. 1A
& C) in diameter while those derived from hypoxic cells were of a
smaller diameter of 61 ± 13 nm (Fig. 1B & C). Western blot analysis
shows enriched presence of exosomal marker CD63, a tetraspanin molecule commonly used as an exosomal marker protein, in exosomes
compared to total U87MG cell lysates (Fig. 1D). These analyses conﬁrm
characterization of isolated vesicles as exosomes.

3. Results

3.2. Quantitative and qualitative changes in exosomal proteome

3.1. Characterization of exosomes derived from hypoxic glioma cells

Our previous ﬁndings on cells’ microenvironment dictating the
exosomal protein content [18], inspired us to investigate changes that
are brought about in the exosomal cargo due to hypoxia. Exosomes
isolated from glioma cells subjected to hypoxic and normoxic conditions were subjected to mass spectrometric analysis. Using the new

could be established with less than 1.0% false discovery and contained
at least 2 identiﬁed peptides; protein probabilities were assigned by the
Protein Prophet algorithm [34] and to perform reporter ion-based statistical analysis. The network analyses were generated through the use
of IPA (QIAGEN Inc., https://www.qiagenbioinformatics.com/
products/ingenuity-pathway-analysis) [35].
2.11. Statistical analyses

Confocal images of U87MG cells conﬁrmed hypoxic stress in cells
cultured in an anaerobic chamber showing increased intensity of pimonidazole staining (Sup Fig S1 A & B) as compared to cells cultured
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Fig. 3. Elevated levels of proteins detected in hypoxic exosomes. (A) Western blot analysis of exosomes isolated from serum free, conditioned media of U87MG cells
cultured under hypoxic conditions. Among the proteins detected in hypoxic exosomes were TSP-1, LOX, ADAMTS1, and VEGF. (B-E) Quantiﬁcation of the western
blots showed a signiﬁcant increase in levels of secreted TSP-1, LOX, ADAMTS1, and VEGF in hypoxic exosomes compared to normoxic exosomes. Hif-1α (F) and
Galectin-1 (G) were found to be elevated in hypoxic cell lysates although the increase was not signiﬁcant. β-actin was used as loading control. Error bars, SEM
(*p < 0.05, **p < 0.01, ***p < 0.001, ns=non signiﬁcant).

agreement with the presented MS quantiﬁcation data.

TMT™ six-plex isobaric mass tagging MS analysis, a quantitative and
comparative analysis of three independent sets of normoxic and hypoxic exosome was carried out. Mass spectra detected 136 diﬀerent
proteins (Supplementary info S1) which were diﬀerentially elevated
(1.2 fold or more) in exosomes derived from cells exposed to hypoxia
compared to those from normoxic cells. An Ingenuity pathway analysis
(IPA) [35] of the hypoxic exosomal proteome showed that these differentially elevated proteins interact with proteins (Supplementary info
S2) regulating various pathways such as upregulating the tumor
growth, cell migration and tumor invasiveness pathways (orange
nodes) while down regulating (blue nodes) the apoptosis and cell death
pathways (Fig. 2).
High grade GBM tumors are characterized by regions of intense
neovascularization. MS analysis of the hypoxic exosomal proteome
detected many of the major players which regulate angiogenesis such as
TSP-1, LOX, VEGF and ADAMTS1. We further utilized the Western blot
technique to validate and quantify these proteins (Fig. 3).
TSP-1 and LOX have been reported to be involved in neovascularization of tumors while the ADAMTS1 has been shown to be involved in
remodeling of ECM. MS analysis showed that these proteins were found
to be signiﬁcantly elevated in the exosomes secreted by cells exposed to
hypoxia. The TSP-1 was found to be elevated 1.8 fold, LOX was elevated
2 fold, VEGF was elevated 2.5 fold while ADAMTS1 was also found to
be elevated 1.8 fold in hypoxic exosomes. These results are in

3.3. Hypoxic exosomes induce angiogenesis and promote cell survival
Glioblastomas are characterized by increase in neovascularization
to sustain growth, survival and proliferation of tumor cells [36–38].
Based on our previous MS and WB results showing elevated levels of
some key players in angiogenesis, we were motivated to investigate the
functional role of exosomes secreted by hypoxic glioma cells on the
surrounding stromal cells.
EPCs were treated with either normoxic or hypoxic exosomes and
the eﬀects on tube formation was measured. Treatment of EPCs with
hypoxic exosomes stimulated tube forming ability in EPCs (Fig. 4A) by
signiﬁcantly increasing the formation of branching intervals (Fig. 4B)
and tube length (Fig. 4C) over normoxic exosomes. Furthermore, although not signiﬁcant, hypoxic exosomes induced a marked overall
increase in the formation of junctions, meshes and isolated branch
lengths in EPCs over normoxic exosomes (Sup Fig. 2 A, B and C).
Hypoxia induces oxidative stress in cells [39–41]. Exosomes provide
substantial cytoprotective eﬀects against oxidative stresses. U87MG
glioma cells were exposed to hydrogen peroxide induced oxidative
stress in the presence or absence of normoxic or hypoxic exosomes.
Cells exposed to oxidative stress showed considerable decrease in cell
viability. However, preincubation of glioma cells with either normoxic
108
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Fig. 4. Angiogenic eﬀects of hypoxic exosomes. (A) In-vitro tube formation assay using
EPC cells was performed in presence of either
normoxic or hypoxic exosomes. A set of 4 different images was analyzed for each treatment
and angiogenesis parameters were tabulated.
Compared to untreated EPCs and those treated
with normoxic exosomes, hypoxic exosome
treatment produced a signiﬁcant increase in
the number of branching intervals, (B) and
tube length, (C) in cultured EPCs. (D)
Exosomes derived from both normoxic and
hypoxic cells conferred signiﬁcant cytoprotective eﬀects to U87MG cells exposed to oxidative stress induced by 0.5 mM H2O2. Error bars,
SEM (*p < 0.05, **p < 0.01).

or hypoxic exosomes for 3–4 h, signiﬁcantly diminished the eﬀects of
oxidative stress induced decrease in cell viability oﬀering signiﬁcant
cytoprotective eﬀects by 25–26% overall. The hypoxic exosomes however, did not oﬀer any noticeable improvement over normoxic exosomes (Fig. 4D).

downregulated gene, the KCNJ3 (potassium voltage gated channel
subfamily J member 3). The signiﬁcant changes observed in the transcriptome of hypoxic exosome treated glioma cells can thus be attributed to the functional exosomal cargo in ultimately regulating gene
expression.

3.4. Exosome treatment induces signiﬁcant changes in the transcriptome of
recipient cells

4. Discussion
A plethora of studies have shed light on how hypoxia plays an important role in tumor development, cell survival, proliferation, angiogenesis, and is involved in imparting intense resistance to multimodality anti-cancer treatments [36,42,43]. High grade gliomas are
characterized by areas of hypoxia in the growing periphery, a necrotic
core, regions of intense angiogenesis, inﬂammation, and resistance to
apoptosis following chemo- and radiation therapy [44–47]. Our investigations into hypoxia and its eﬀects on the exosomes secreted by
glioma cells point to some of the molecular mechanisms which may
explain the stimulated angiogenesis and resistance to apoptosis observed in many pre-clinical and clinical studies on GBM [42,46]. In
general, the tumor microenvironment including the oxygen status surrounding tumor cells profoundly aﬀects how cancer cells respond to
chemo- and radiation therapies. Previous reports have shown that
changes in the tissue microenvironment induce changes in the proteome and transcriptome of a cell [18]. Subsequently our study, in
agreement with other recent reports [9,18,26–28,48] have shown that
these changes are reﬂected in the cargo of exosomes secreted by such
cells. Glioma cells grown under hypoxic conditions show a marked
increase in staining for pimonidazole adducts along with over expression of Hif-1α and galectin-1 (Fig. 3), both proteins usually over-expressed under hypoxic conditions.
Based on previous studies, we anticipated a change in the exosomal
proteome under hypoxic stress [18,26]. The physical, genetic and
proteomic characteristics of secreted exosomes can vary due to the
microenvironment they are produced from. Characterization of glioma
exosomes revealed that the stress induced due to hypoxic conditions
aﬀects the exosome size distribution. Exosomes secreted by hypoxic

Intrigued by the response to exosomes by glioma cells under oxidative stress, we investigated the transcriptional changes in these cells
as a consequence to exposure to either normoxic or hypoxic exosomes.
U87MG cells grown in complete media supplemented with exosome
free FBS were treated with hypoxic or normoxic exosomes. 24 h later,
RNA was isolated from treated or untreated cells and the transcriptome
of these cells was sequenced. Untreated cells were used as controls for
RNA sequencing analysis. Compared to the transcriptome of untreated
cells, in cells treated with normoxic exosomes, 29 diﬀerentially expressed (DE) genes were identiﬁed out of a total of 13102 genes detected (Supplementary info S3). Those genes which were found to be
upregulated (Table 1 A – bold italics) were involved in apoptosis, interleukin signaling and cytokine mediated inﬂammation pathways
(Fig. 5A). Downregulated genes (Table 1 A regular font) were found to
be involved in TGF-beta, Wnt, Cadherin pathways.
Of the 6067 genes (Supplementary info S4) induced in cells exposed
to hypoxic exosomes (Table 1 B – bold italics), ﬁve were signiﬁcantly
upregulated. The ﬁve genes are SNORD1, KCNJ8, C4orf48, C1QTNF2,
and DRGX. Of the 7257 genes repressed (Table 1 B – regular font) in
cells exposed to hypoxic exosomes, nine were signiﬁcantly downregulated. These nine genes are CBS, PAPPA2, MALAT1, PPL, STON1,
CDR1, KCNT2, PCDH1, and KCNJ3.
The list of diﬀerentially expressed genes was then analyzed for their
pathways using the QIAGEN Integrated Pathways Analysis software
[35] (Fig. 5A and B).
Analysis of the hypoxic exosome treated glioma cell transcriptome
results showed that majority of these pathways are aﬀected by a single
109
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formation, mesh formation, number of branching intervals among other
outputs in EPC cultured or treated with hypoxic exosomes. These results
seem to implicate a pathway for the well-studied eﬀect of hypoxia
promoting increased neovascularization in the tumor microenvironment [27,36–38,44].
Although we found a general cytoprotective eﬀect vis-à-vis normoxic or hypoxic exosomes, the eﬀect of hypoxic exosomes on the
transcriptome of glioma cells was signiﬁcantly diﬀerent compared to
the one induced by normoxic exosomes. RNA seq analysis showed a
number of diﬀerentially expressed genes and shown in Table 1. Although the number of genes diﬀerentially selectively expressed in cells
treated with hypoxic exosomes was far lesser than the total genes induced by exosomes in general, there were major changes which help to
explain how hypoxia might modulate the tumor environment and assist
the tumor in progressing and resisting various therapeutic insults.
We were able to examine pathway analysis to identify a series of
cellular functions likely to be induced in cells after exposure to hypoxic
exosomes. Analysis of the hypoxia-exosome induced U87MG glial
tumor cell transcriptome showed various metabolic pathway interruptions. Several of these interruptions were within amino acid metabolism
and involved the biosynthesis of amino acids in general. Amino acid
deﬁciency has been found to positively correlate with tumor angiogenesis that was induced with VEGF (vascular endothelial growth
factor). Cystathionine-beta-synthase (CBS), which codes for the protein
to catalyze the conversion of homocysteine to cystathionine, is the ﬁrst
step along the transsulfuration pathway, and a repression of CBS would
inevitably retard amino acid biosynthesis which could activate the
VEGF pathway in areas of hypoxia or those adjacent to hypoxic cells
[53]. If these pathways are activated by a hypoxic tumor, it may be a
link to neurological deﬁcits associated with aggressive tumor growth,
mediated by secreted exosomes from hypoxic regions.
Pathway analysis also identiﬁed possible interaction with the cGMPPKG signaling pathway. Protein Kinase G is typically activated by cGMP
and has downstream interactions that regulate a variety of physiological processes [54]. One of the downstream interactions is with mitochondrial ATP-sensitive potassium channels (mKATP) [55]. The
speciﬁc mKATP is KCNJ8, which is a potassium ion channel [56].
Opening of the mKATP causes an increased concentration of reactive
oxygen species (ROS). The ROS causes a feedback activation of the
mKATP channel, leaving the channel open for a prolonged period of
time, creating more ROS, which could lead to enhanced activity of the
cell. For instance, the ROS may cause the intrinsic process of ischemic
preconditioning (IPC) to occur. During IPC, short episodes of ischemia
are repeatedly induced leading to an activated state of protective enzymatic pathways to reduce the impact/induce tolerance to subsequent
ischemic incidents.
The down regulated genes were found to be involved in Wnt, GABABrII, and Cadherin mediated pathways. PCDH1, Stonin-1, and MALAT1
are all involved in intercellular communication. Stonin-1 is a noncoding RNA and MALAT1 is a non-protein coding gene [57]. PCDH1 is
involved in both of the distinct categories. It is a membrane protein
found at cell-to-cell boundaries [58], but it is also involved in neural
cell adhesion [59].
The second and much more direct theme of these repressed genes is
that of neurological functionality. Two genes (KCNT2 and KCNJ3) are
voltage-gated potassium channels [60]. KCNT2 is an ATP-sensitive
outward rectifying potassium channel. KCNJ3 is a G-protein controlled
inward-rectifying potassium channel. CDR1 is a cerebellar degeneration
related protein, and has been found in patients with paraneoplastic
cerebellar degeneration [61]. PAPPA2 codes for a protein that cleaves
insulin-like growth factor (IGF) which modulates neurological function.
PPL codes for a protein that is suspected to be a contributor to intermediate ﬁlament, which provide cells with their structure. CBS codes
for cystathionine-beta-synthase, which is a crucial intermediate in the
transsulfuration pathway. The inhibition of CBS has been shown to
eﬀect a variety of biochemical processes, including the synthesis of

Table 1
Genes diﬀerentially expressed.
A
symbol

entrez

logfc

adjpv

CXCL8
CXCL1
CSF2
TNFAIP3
GPX3
BIRC3
KCCAT211
RNF144B
IL1B
CCL2
SLC43A2
CSF3
SERPINB2
PPL
CLDN1
IL20RB
STON1
AKNA
DNAH10
C6orf223
PAPPA2
SPRR2D
ANKRD22
KCNT2
INHBE
CDR1
CBS
MLXIPL
PCDH1

3576
2919
1437
7128
2878
330
102724550
255488
3553
6347
124935
1440
5055
5493
9076
53833
11037
80709
196385
221416
60676
6703
118932
343450
83729
1038
875
51085
5097

1.29433
1.24651
1.00003
0.878881
0.877069
0.84613
0.79094
0.776609
0.771501
0.667585
0.655362
0.627342
0.623376
− 0.605729
− 0.606167
− 0.607983
− 0.624714
− 0.627865
− 0.633545
− 0.66998
− 0.671331
− 0.675693
− 0.678226
− 0.683391
− 0.694873
− 0.697316
− 0.906225
− 0.949305
− 1.27402

0.011312
0.011312
0.011312
0.011312
0.035951
0.011312
0.011312
0.011312
0.011312
0.011312
0.011312
0.011312
0.011312
0.011312
0.035951
0.011312
0.011312
0.011312
0.011312
0.035951
0.011312
0.011312
0.035951
0.011312
0.011312
0.011312
0.011312
0.021512
0.031243

B
symbol

entrez

logfc

adjpv

SNORD116-21
KCNJ8
C1QTNF2
DRGX
C4orf48
CBS
PAPPA2
MALAT1
PPL
STON1
CDR1
KCNT2
PCDH1
KCNJ3

100033432
3764
114898
644168
401115
875
60676
378938
5493
11037
1038
343450
5097
3760

10
1.08844
0.998243
0.915825
0.882413
− 0.640255
− 0.640677
− 0.646721
− 0.691949
− 0.700129
− 0.733006
− 0.834774
− 1.05263
− 1.34574

0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899
0.013899

Genes signiﬁcantly expressed in U87MG cells treated with normoxic exosomes
(A) and cells treated with hypoxic exosomes (B). The genes listed in bold italics
are signiﬁcantly elevated and others signiﬁcantly down regulated with logfc
giving their fold change values along with their adjusted p values (adjpv)
(n = 3).

cells were found to be of smaller size compared to normoxic cells. Our
major eﬀort in the work that followed was to understand the diﬀerences
in the function of these hypoxic exosomes vs. exosomes secreted from
normoxic cells. Prior studies have shown that exosomes in general
impart signiﬁcant cytoprotective eﬀects against various stresses to cells
[48–52]. Our results did agree with these observations. However, we
did not ﬁnd any signiﬁcant diﬀerence in the cytoprotective eﬀect
against oxidative stress aﬀorded by hypoxic exosomes compared to
normoxic exosomes. We attribute this eﬀect to the fact that even our
‘normoxic’ exosomes are derived from a glioma cell line and they all
exhibit some level of cytoprotective eﬀect when added to stressed cells,
a result of carrying oncogenic cargo promoting cell survivability.
However, the eﬀect of these exosomes on EPC tube formation markedly
diﬀered. Hypoxic exosomes induced a clear increase in the node
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Fig. 5. Network analysis of diﬀerentially expressed genes in glioma cells exposed to exosomes. Ingenuity pathway analysis based on RNA seq results for diﬀerentially
expressed genes in U87MG cells treated with normoxic exosomes (A) and hypoxic exosomes (B) shows regulation of varying pathways depending on the exosome
source. Genes brighter in color are elevated while the fainter ones are downregulated.

inﬂammation, neovascularization and aggressive tumor growth. Many
of these processes are modulated via intercellular communication
through exosomes. The cargo of these exosomes changes depending on
the microenvironment of the secreting cells. Hypoxic conditions, as
seen in GBM tumor necrotic cores and their aggressively proliferating
edges, induce changes in the cargo of exosomes secreted by glioma cells
residing in these areas. The target cells of these exosomes react to the
exosomal messages by diﬀerential expression of many genes. Based on
our experimental results and pathway and network analysis of exosomal proteomic and target cell transcriptome results, the result of intercellular communication mediated by hypoxic exosomes, in part,
explains why GBM tumors oﬀer such intense resistance to aggressive
multimodality anti-neoplastic treatments and such high rates of tumor
recurrence. Our studies shed light on potential targets carried by exosomes and also provide information on the various genes that are differentially expressed which can potentially be targeted to halt the advance of proliferating cancer cells. By controlling the
microenvironment of cells secreting exosomes, these vesicles can potentially be engineered to carry agents or drugs to target speciﬁc cancer
cells thus avoiding or circumventing the dangerous side-eﬀects of antineoplastic molecules.
Overall, our results suggest that glioblastoma tumor cells, growing
in regions of hypoxia can secrete speciﬁc programs for changing
neighboring or remote cell gene and protein expression, possibly contributing in a major way to progression and resistance of diﬃcult to
manage cancers such as GBM.

glutathione [53]. One of the pathways that is aﬀected by the downregulation of this particular gene is the oxytocin signaling pathway, the
dysregulation of which negatively aﬀects proliferation, diﬀerentiation
and cellular migration.
There were also a number of signiﬁcantly upregulated genes in
glioma cells that were exposed to hypoxic exosomes and there were two
prominent categories that emerged in our analysis. The ﬁrst is that of
intercellular communication. SNORD116-21 (HBII-85-21) [62,63] is a
small nucleolar RNA that could easily have been a component of the
exosome communication, and C1QTNF1 which is a tumor necrosis
factor related protein. Interestingly, the levels of small nucleolar RNA,
SNORD116-21 was found to be increased 10-fold. In all, over half of the
increased expression genes involve neuronal function and development.
As mentioned, KCNJ8 is a voltage-gated potassium channel, critical to
neurological membrane polarization. C4orf48 is a protein that has been
shown to increase expression during neocortex and cerebellar development, and DRGX is the gene for the dorsal root ganglia homeobox,
which is thought to relate to axon guidance.
The diﬀerential expression of genes in glioma cells exposed to hypoxic exosomes throws light on the paracrine signaling mechanisms
which help the neighboring and exosome recipient tumor cells react to
hypoxic microenvironment. Hypoxic exosomal proteins from glioma
cells were found to carry a complement of proteins which were involved in proliferation of cells, proliferation of endothelial cells invasion of tumor, suppression of cell death, among other pathways (Fig. 4A
and B). Many of the proteins identiﬁed are known to play an important
role in tumor invasion and angiogenesis. Among the culprits identiﬁed
were Protein-lysine 6-oxidase, Thrombospondin-1, Vascular endothelial
growth factor and A disintegrin and metalloproteinase with thrombospondin motifs-1. Probing Western blots of hypoxic exosome proteins, we were able to conﬁrm the elevated levels of LOX, ADAMTS1
and VEGF, known participants in hypoxia- induced angiogenesis and
metastasis [64–67], as well as Thrombospondin-1, known to be integrally related to vascular function/activation status and aberrant
tumor vascularization [10,18,68–70] in hypoxic exosomes. The transformation observed in the EPCs and the diﬀerential expression of genes
observed in the transcriptome of glioma cells treated with hypoxic
exosomes can thus be attributed to the changes in the cargo of exosomes due to hypoxic stress.
The clinical manifestations in patients suﬀering from high grade
gliomas such as cognitive disturbances, communication deﬁcits, neurological deﬁcits, seizures [71,72] are due to the necrosis,
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